title: Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3'-, 5'-phosphorodithioate, a second cAMP antagonist.
abstract: A single sulfur substitution for either the axial or the equatorial exocyclic oxygen of adenosine cyclic 3', 5'-phosphate (cAMP) results in diastereometric phosphorothioate analogs of cAMP with agonist versus antagonist properties towards activation of cAMP-dependent protein kinase. Sulfur substitutions for both of the exocyclic oxygens of cAMP results in a dithioate analog of cAMP, adenosine cyclic 3', 5'-phosphorodithioate (cAMPS2), which has antagonist properties. cAMPS2 displaced [3H]cAMP from the binding sites on bovine heart Type II cAMP-dependent protein kinase as demonstrated by equilibrium dialysis experiments with an apparent Kd of 6.3 microM. The addition of 10, 30, or 100 microM cAMPS2 when measuring cAMP-induced activation of pure porcine heart Type II cAMP-dependent protein kinase resulted in a concentration-dependent increase in the amount of cAMP required to produce half-maximal activation (EC50). A plot of the EC50 values as a function of the cAMPS2 concentration resulted in a straight line from which a KI value of 4 microM was derived. cAMPS2 had no significant effect on the degree of cooperativity (n) of cAMP activation of the holoenzyme. These data suggest that the most important structural requirement for the dissociation of the holoenzyme is an equatorial exocyclic oxygen.
authors.affiliation: Sandoz Research Institute, Sandoz, Inc., East Hanover, New Jersey 07936.
authors.forename: L H
authors.initials: LH
authors.lastname: Botelho
authors.forename: L C
authors.initials: LC
authors.lastname: Webster
authors.forename: J D
authors.initials: JD
authors.lastname: Rothermel
authors.forename: J
authors.initials: J
authors.lastname: Baraniak
authors.forename: W J
authors.initials: WJ
authors.lastname: Stec
mesh_terms: D000465:Algorithms; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003198:Computer Simulation; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D008958:Models, Molecular; D009206:Myocardium / Q000201:enzymology; D047428:Protein Kinase Inhibitors; D013329:Structure-Activity Relationship; D013455:Sulfur; D013552:Swine; D013873:Thionucleotides / Q000494:pharmacology*
chemical_list: D047428:Protein Kinase Inhibitors; D013873:Thionucleotides; C016957:adenosine-3',5'-cyclic phosphorothioate; D013455:Sulfur; D000242:Cyclic AMP